Stability profiles differ Tirzepatide has a slightly different molecular structure as a dual GIP/GLP-1 receptor agonist, and its stability profile in insulin syringes has not been studied as extensively as semaglutide
If not, do I need B separately
Patients ask this because GLP1 receptor agonists (often called GLP1 analogs or GLP1 inhibitors in everyday conversation) commonly cause nausea, vomiting, and slowed stomach emptying
Similarly, severe gastrointestinal distress, including intense nausea, vomiting, or diarrhoea, or episodes of low blood sugar, may require dose adjustments or additional interventions to keep you safe
It is safe for long-term use when followed by the recommended dosage
According to a 2021 article published in the European Journal of Allergy and Clinical Immunology, hypersensitivity reactions to chemotherapy drugs is somewhat rare, with a few exceptions